Description
Tirzepatide is a long-acting peptide-based agonist of both the GIP receptor and GLP-1 receptor. Its dual-receptor activity has made it an important compound in metabolic and endocrine research.
Research and clinical development have examined tirzepatide in relation to glucose-dependent insulin secretion, glucagon regulation, appetite signaling, gastric emptying, body-weight regulation, and broader metabolic physiology. FDA-approved tirzepatide products are available under specific product names and indications; research-grade material supplied separately should not be represented as equivalent to those approved products.
Our product is supplied as a lyophilized research material in 3 mL vials containing either 30 mg or 60 mg, with BAC Water specified as the diluent.
COA: Click the links below for Janoshik Test Results
BCX Black Cap 30mg Janoshik Test
BCX Copper Tin/Clear Cap 60mg Janoshik Test
Research Use Only. Not for Human or Veterinary Use. These products are not intended to diagnose, treat, cure, or prevent any disease. Product information is provided for research and educational purposes only.
Reviews
There are no reviews yet.